腫瘍学におけるコンパニオン診断テストの世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)

【英語タイトル】Global Companion Diagnostic Tests in Oncology Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

GlobalInfoResearchが出版した調査資料(GIR8101318)・商品コード:GIR8101318
・発行会社(調査会社):GlobalInfoResearch
・発行日:2018年9月13日
・ページ数:118
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:世界
・産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、腫瘍学におけるコンパニオン診断テストの世界市場について調べ、まとめました。種類別セグメントは、タンパク質検出、DNA検出等、用途別セグメントは、医薬品およびバイオテクノロジー企業、医療機器企業、研究機関等に区分しました。腫瘍学におけるコンパニオン診断テストの世界市場概観、メーカー動向、メーカー別腫瘍学におけるコンパニオン診断テストシェア、市場規模推移、市場規模予測、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどの情報が含まれています。
・腫瘍学におけるコンパニオン診断テストの市場概観
・腫瘍学におけるコンパニオン診断テストのメーカー概要(事業概要、製品種類、価格、売上、市場シェア等)
・腫瘍学におけるコンパニオン診断テストのメーカー別販売動向、市場シェア、市場集中度、競争動向
・腫瘍学におけるコンパニオン診断テストの世界市場規模
・腫瘍学におけるコンパニオン診断テストの北米市場分析(アメリカ、カナダ、メキシコ等)
・腫瘍学におけるコンパニオン診断テストのアメリカ市場規模推移
・腫瘍学におけるコンパニオン診断テストのカナダ市場規模推移
・腫瘍学におけるコンパニオン診断テストのメキシコ市場規模推移
・腫瘍学におけるコンパニオン診断テストのヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・腫瘍学におけるコンパニオン診断テストのドイツ市場規模推移
・腫瘍学におけるコンパニオン診断テストのイギリス市場規模推移
・腫瘍学におけるコンパニオン診断テストのロシア市場規模推移
・腫瘍学におけるコンパニオン診断テストのアジア市場分析(日本、中国、韓国、インド、東南アジア等)
・腫瘍学におけるコンパニオン診断テストの日本市場規模推移
・腫瘍学におけるコンパニオン診断テストの中国市場規模推移
・腫瘍学におけるコンパニオン診断テストの韓国市場規模推移
・腫瘍学におけるコンパニオン診断テストのインド市場規模推移
・腫瘍学におけるコンパニオン診断テストの東南アジア市場規模推移
・腫瘍学におけるコンパニオン診断テストの南米市場分析(ブラジル、アルゼンチン等)
・腫瘍学におけるコンパニオン診断テストの中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・腫瘍学におけるコンパニオン診断テストの種類別分析/市場規模推移(タンパク質検出、DNA検出)
・腫瘍学におけるコンパニオン診断テストの用途別分析/市場規模推移(医薬品およびバイオテクノロジー企業、医療機器企業、研究機関)
・腫瘍学におけるコンパニオン診断テストの市場予測(地域別予測、種類別予測、用途別予測)
・腫瘍学におけるコンパニオン診断テストの販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Increasing incidence of cancer, rising cost burden of cancer treatment, and increasing mortalities due to cancer, are some of the major reasons for increasing demand for new and technologically advanced treatment options, therapies, and drugs for the treatment of cancer.

Scope of the Report:

This report studies the Companion Diagnostic Tests in Oncology market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Companion Diagnostic Tests in Oncology market by product type and applications/end industries.

The global Companion Diagnostic Tests in Oncology market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Companion Diagnostic Tests in Oncology.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Abbott

Roche

Genomic Health

QIAGEN

Agilent

Agendia

BioMerieux

Illumina

Siemens Healthcare

Thermo Fisher

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Protein Detection

DNA Detection

Market Segment by Applications, can be divided into

Pharmaceutical & Biotechnology Companies

Medical Device Companies

Research Institutes

【レポートの目次】

Table of Contents

1 Companion Diagnostic Tests in Oncology Market Overview

1.1 Product Overview and Scope of Companion Diagnostic Tests in Oncology

1.2 Classification of Companion Diagnostic Tests in Oncology by Types

1.2.1 Global Companion Diagnostic Tests in Oncology Revenue Comparison by Types (2017-2023)

1.2.2 Global Companion Diagnostic Tests in Oncology Revenue Market Share by Types in 2017

1.2.3 Protein Detection

1.2.4 DNA Detection

1.3 Global Companion Diagnostic Tests in Oncology Market by Application

1.3.1 Global Companion Diagnostic Tests in Oncology Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Pharmaceutical & Biotechnology Companies

1.3.3 Medical Device Companies

1.3.4 Research Institutes

1.4 Global Companion Diagnostic Tests in Oncology Market by Regions

1.4.1 Global Companion Diagnostic Tests in Oncology Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Companion Diagnostic Tests in Oncology Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Companion Diagnostic Tests in Oncology Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Companion Diagnostic Tests in Oncology Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Companion Diagnostic Tests in Oncology Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Companion Diagnostic Tests in Oncology Status and Prospect (2013-2023)

1.5 Global Market Size of Companion Diagnostic Tests in Oncology (2013-2023)

2 Manufacturers Profiles

2.1 Abbott

2.1.1 Business Overview

2.1.2 Companion Diagnostic Tests in Oncology Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Abbott Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

2.2 Roche

2.2.1 Business Overview

2.2.2 Companion Diagnostic Tests in Oncology Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Roche Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

2.3 Genomic Health

2.3.1 Business Overview

2.3.2 Companion Diagnostic Tests in Oncology Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Genomic Health Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

2.4 QIAGEN

2.4.1 Business Overview

2.4.2 Companion Diagnostic Tests in Oncology Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 QIAGEN Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

2.5 Agilent

2.5.1 Business Overview

2.5.2 Companion Diagnostic Tests in Oncology Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Agilent Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

2.6 Agendia

2.6.1 Business Overview

2.6.2 Companion Diagnostic Tests in Oncology Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Agendia Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

2.7 BioMerieux

2.7.1 Business Overview

2.7.2 Companion Diagnostic Tests in Oncology Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 BioMerieux Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

2.8 Illumina

2.8.1 Business Overview

2.8.2 Companion Diagnostic Tests in Oncology Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Illumina Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

2.9 Siemens Healthcare

2.9.1 Business Overview

2.9.2 Companion Diagnostic Tests in Oncology Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Siemens Healthcare Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

2.10 Thermo Fisher

2.10.1 Business Overview

2.10.2 Companion Diagnostic Tests in Oncology Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Thermo Fisher Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

3 Global Companion Diagnostic Tests in Oncology Market Competition, by Players

3.1 Global Companion Diagnostic Tests in Oncology Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Companion Diagnostic Tests in Oncology Players Market Share

3.2.2 Top 10 Companion Diagnostic Tests in Oncology Players Market Share

3.3 Market Competition Trend

4 Global Companion Diagnostic Tests in Oncology Market Size by Regions

4.1 Global Companion Diagnostic Tests in Oncology Revenue and Market Share by Regions

4.2 North America Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

4.3 Europe Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

4.5 South America Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

5 North America Companion Diagnostic Tests in Oncology Revenue by Countries

5.1 North America Companion Diagnostic Tests in Oncology Revenue by Countries (2013-2018)

5.2 USA Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

5.3 Canada Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

5.4 Mexico Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

6 Europe Companion Diagnostic Tests in Oncology Revenue by Countries

6.1 Europe Companion Diagnostic Tests in Oncology Revenue by Countries (2013-2018)

6.2 Germany Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

6.3 UK Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

6.4 France Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

6.5 Russia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

6.6 Italy Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Companion Diagnostic Tests in Oncology Revenue by Countries

7.1 Asia-Pacific Companion Diagnostic Tests in Oncology Revenue by Countries (2013-2018)

7.2 China Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

7.3 Japan Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

7.4 Korea Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

7.5 India Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

8 South America Companion Diagnostic Tests in Oncology Revenue by Countries

8.1 South America Companion Diagnostic Tests in Oncology Revenue by Countries (2013-2018)

8.2 Brazil Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

8.3 Argentina Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

8.4 Colombia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Companion Diagnostic Tests in Oncology by Countries

9.1 Middle East and Africa Companion Diagnostic Tests in Oncology Revenue by Countries (2013-2018)

9.2 Saudi Arabia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

9.3 UAE Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

9.4 Egypt Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

9.5 Nigeria Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

9.6 South Africa Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

10 Global Companion Diagnostic Tests in Oncology Market Segment by Type

10.1 Global Companion Diagnostic Tests in Oncology Revenue and Market Share by Type (2013-2018)

10.2 Global Companion Diagnostic Tests in Oncology Market Forecast by Type (2018-2023)

10.3 Protein Detection Revenue Growth Rate (2013-2023)

10.4 DNA Detection Revenue Growth Rate (2013-2023)

11 Global Companion Diagnostic Tests in Oncology Market Segment by Application

11.1 Global Companion Diagnostic Tests in Oncology Revenue Market Share by Application (2013-2018)

11.2 Companion Diagnostic Tests in Oncology Market Forecast by Application (2018-2023)

11.3 Pharmaceutical & Biotechnology Companies Revenue Growth (2013-2018)

11.4 Medical Device Companies Revenue Growth (2013-2018)

11.5 Research Institutes Revenue Growth (2013-2018)

12 Global Companion Diagnostic Tests in Oncology Market Size Forecast (2018-2023)

12.1 Global Companion Diagnostic Tests in Oncology Market Size Forecast (2018-2023)

12.2 Global Companion Diagnostic Tests in Oncology Market Forecast by Regions (2018-2023)

12.3 North America Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)

12.4 Europe Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)

12.6 South America Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures



Figure Companion Diagnostic Tests in Oncology Picture

Table Product Specifications of Companion Diagnostic Tests in Oncology

Table Global Companion Diagnostic Tests in Oncology and Revenue (Million USD) Market Split by Product Type

Figure Global Companion Diagnostic Tests in Oncology Revenue Market Share by Types in 2017

Figure Protein Detection Picture

Figure DNA Detection Picture

Table Global Companion Diagnostic Tests in Oncology Revenue (Million USD) by Application (2013-2023)

Figure Companion Diagnostic Tests in Oncology Revenue Market Share by Applications in 2017

Figure Pharmaceutical & Biotechnology Companies Picture

Figure Medical Device Companies Picture

Figure Research Institutes Picture

Table Global Market Companion Diagnostic Tests in Oncology Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2013-2023)

Table Abbott Basic Information, Manufacturing Base and Competitors

Table Abbott Companion Diagnostic Tests in Oncology Type and Applications

Table Abbott Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

Table Roche Basic Information, Manufacturing Base and Competitors

Table Roche Companion Diagnostic Tests in Oncology Type and Applications

Table Roche Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

Table Genomic Health Basic Information, Manufacturing Base and Competitors

Table Genomic Health Companion Diagnostic Tests in Oncology Type and Applications

Table Genomic Health Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

Table QIAGEN Basic Information, Manufacturing Base and Competitors

Table QIAGEN Companion Diagnostic Tests in Oncology Type and Applications

Table QIAGEN Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

Table Agilent Basic Information, Manufacturing Base and Competitors

Table Agilent Companion Diagnostic Tests in Oncology Type and Applications

Table Agilent Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

Table Agendia Basic Information, Manufacturing Base and Competitors

Table Agendia Companion Diagnostic Tests in Oncology Type and Applications

Table Agendia Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

Table BioMerieux Basic Information, Manufacturing Base and Competitors

Table BioMerieux Companion Diagnostic Tests in Oncology Type and Applications

Table BioMerieux Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

Table Illumina Basic Information, Manufacturing Base and Competitors

Table Illumina Companion Diagnostic Tests in Oncology Type and Applications

Table Illumina Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

Table Siemens Healthcare Basic Information, Manufacturing Base and Competitors

Table Siemens Healthcare Companion Diagnostic Tests in Oncology Type and Applications

Table Siemens Healthcare Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

Table Thermo Fisher Basic Information, Manufacturing Base and Competitors

Table Thermo Fisher Companion Diagnostic Tests in Oncology Type and Applications

Table Thermo Fisher Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

Table Global Companion Diagnostic Tests in Oncology Revenue (Million USD) by Players (2013-2018)

Table Global Companion Diagnostic Tests in Oncology Revenue Share by Players (2013-2018)

Figure Global Companion Diagnostic Tests in Oncology Revenue Share by Players in 2016

Figure Global Companion Diagnostic Tests in Oncology Revenue Share by Players in 2017

Figure Global Top 5 Players Companion Diagnostic Tests in Oncology Revenue Market Share in 2017

Figure Global Top 10 Players Companion Diagnostic Tests in Oncology Revenue Market Share in 2017

Figure Global Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Companion Diagnostic Tests in Oncology Revenue (Million USD) by Regions (2013-2018)

Table Global Companion Diagnostic Tests in Oncology Revenue Market Share by Regions (2013-2018)

Figure Global Companion Diagnostic Tests in Oncology Revenue Market Share by Regions (2013-2018)

Figure Global Companion Diagnostic Tests in Oncology Revenue Market Share by Regions in 2017

Figure North America Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure Europe Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure South America Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Table North America Companion Diagnostic Tests in Oncology Revenue by Countries (2013-2018)

Table North America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018)

Figure North America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018)

Figure North America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries in 2017

Figure USA Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure Canada Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure Mexico Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Table Europe Companion Diagnostic Tests in Oncology Revenue (Million USD) by Countries (2013-2018)

Figure Europe Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018)

Figure Europe Companion Diagnostic Tests in Oncology Revenue Market Share by Countries in 2017

Figure Germany Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure UK Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure France Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure Russia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure Italy Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Companion Diagnostic Tests in Oncology Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Companion Diagnostic Tests in Oncology Revenue Market Share by Countries in 2017

Figure China Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure Japan Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure Korea Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure India Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Table South America Companion Diagnostic Tests in Oncology Revenue by Countries (2013-2018)

Table South America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018)

Figure South America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018)

Figure South America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries in 2017

Figure Brazil Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure Argentina Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure Colombia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Companion Diagnostic Tests in Oncology Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Companion Diagnostic Tests in Oncology Revenue Market Share by Countries in 2017

Figure Saudi Arabia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure UAE Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure Egypt Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure Nigeria Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure South Africa Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Table Global Companion Diagnostic Tests in Oncology Revenue (Million USD) by Type (2013-2018)

Table Global Companion Diagnostic Tests in Oncology Revenue Share by Type (2013-2018)

Figure Global Companion Diagnostic Tests in Oncology Revenue Share by Type (2013-2018)

Figure Global Companion Diagnostic Tests in Oncology Revenue Share by Type in 2017

Table Global Companion Diagnostic Tests in Oncology Revenue Forecast by Type (2018-2023)

Figure Global Companion Diagnostic Tests in Oncology Market Share Forecast by Type (2018-2023)

Figure Global Protein Detection Revenue Growth Rate (2013-2018)

Figure Global DNA Detection Revenue Growth Rate (2013-2018)

Table Global Companion Diagnostic Tests in Oncology Revenue by Application (2013-2018)

Table Global Companion Diagnostic Tests in Oncology Revenue Share by Application (2013-2018)

Figure Global Companion Diagnostic Tests in Oncology Revenue Share by Application (2013-2018)

Figure Global Companion Diagnostic Tests in Oncology Revenue Share by Application in 2017

Table Global Companion Diagnostic Tests in Oncology Revenue Forecast by Application (2018-2023)

Figure Global Companion Diagnostic Tests in Oncology Market Share Forecast by Application (2018-2023)

Figure Global Pharmaceutical & Biotechnology Companies Revenue Growth Rate (2013-2018)

Figure Global Medical Device Companies Revenue Growth Rate (2013-2018)

Figure Global Research Institutes Revenue Growth Rate (2013-2018)

Figure Global Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Companion Diagnostic Tests in Oncology Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Companion Diagnostic Tests in Oncology Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)

Figure Europe Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)

Figure South America Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)



【レポートのキーワード】

腫瘍学におけるコンパニオン診断テスト、タンパク質検出、DNA検出、医薬品およびバイオテクノロジー企業、医療機器企業、研究機関

★調査レポート[腫瘍学におけるコンパニオン診断テストの世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)] (コード:GIR8101318)販売に関する免責事項を必ずご確認ください。
★調査レポート[腫瘍学におけるコンパニオン診断テストの世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆